What is going on with Clearmind Medicine Inc? Sentiment Analysis

Currently, Clearmind Medicine Inc’s (CMND) stock is trading at $1.12, marking a fall of -0.88% from last night’s close. At this price, the stock is -48.62% below its 52-week high of $2.18 and 40.00% above its 52-week low of $0.80. Based on the past 30-day period, the stock price is -13.79% below the high and +33.61% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CMND’s SMA-200 is $1.2011.

CMND’s price to book ratio for the most recent quarter was 2.50, resulting in an 1.30 price to cash per share for the period.

How does Clearmind Medicine Inc (CMND) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.

Clearmind Medicine Inc (CMND): Earnings History

If we examine Clearmind Medicine Inc’s recent earnings history, in the last quarter ended on Next Year (1970), it posted adjusted earnings per share of $0, slashing the consensus of $0. In other words, it topped the consensus by $0, resulting in a 0 surprise. In the 3 months period before the previous quarter which was closed on Next Year (1970), the stock recorded adjusted earnings per share of $0 in contrast with the Outlook of $0. That was a difference of $0 and a surprise of 0.

Clearmind Medicine Inc (NASDAQ: CMND) Ownership Details

I will give a breakdown of the key shareholders in Clearmind Medicine Inc (CMND). Recent figures show that the company’s insiders hold 2.80% of shares. A total of 7 institutional investors hold shares in the company, making 10.91% of its stock and 11.22% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Gotham Asset Management, LP holding total of 343.43 shares that make 8.05% of the company’s total number of shares and are currently priced at 0.38 million.

The securities firm AdvisorShares Investments, LLC holds 220.93 shares of CMND, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 5.18% , and the holding percentage of shares is valued at 0.25 million.

An overview of Clearmind Medicine Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Clearmind Medicine Inc (CMND) traded 2,450,237 shares per day, with a moving average of $0.9873 and price change of +0.2307. With the moving average of $0.9586 and a price change of +0.1628, about 1,042,295 shares changed hands on average over the past 50 days. Finally, CMND’s 100-day average volume is 654,283 shares, alongside a moving average of $1.0045 and a price change of -0.0907.

Hot this week

Yext Inc (YEXT) stock analysis: A comprehensive overview

While Yext Inc has overperformed by 0.22%, investors are...

Zevra Therapeutics Inc (ZVRA)’s stock price range in the last year

While Zevra Therapeutics Inc has underperformed by -0.64%, investors...

Kontoor Brands Inc (KTB) stock: A year of ups and downs

While Kontoor Brands Inc has underperformed by -1.58%, investors...

How to interpret Arcutis Biotherapeutics Inc (ARQT)’s stock chart patterns

While Arcutis Biotherapeutics Inc has underperformed by -1.02%, investors...

Legend Biotech Corp ADR (LEGN) stock on the rise: An overview

While Legend Biotech Corp ADR has underperformed by -1.01%,...

Topics

Yext Inc (YEXT) stock analysis: A comprehensive overview

While Yext Inc has overperformed by 0.22%, investors are...

Zevra Therapeutics Inc (ZVRA)’s stock price range in the last year

While Zevra Therapeutics Inc has underperformed by -0.64%, investors...

Kontoor Brands Inc (KTB) stock: A year of ups and downs

While Kontoor Brands Inc has underperformed by -1.58%, investors...

How to interpret Arcutis Biotherapeutics Inc (ARQT)’s stock chart patterns

While Arcutis Biotherapeutics Inc has underperformed by -1.02%, investors...

Legend Biotech Corp ADR (LEGN) stock on the rise: An overview

While Legend Biotech Corp ADR has underperformed by -1.01%,...

What technical indicators reveal about CHYM stock

While Chime Financial Inc has overperformed by 1.33%, investors...

Teradata Corp (TDC) stock analysis: A simple moving average approach

While Teradata Corp has overperformed by 0.09%, investors are...

Aldeyra Therapeutics Inc (ALDX)’s highs and lows: A closer look at its stock price fluctuations

While Aldeyra Therapeutics Inc has overperformed by 0.17%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.